Brought to you by 
CardioDx gets $34.6mm through Series D venture round
27 May 2010
Executive Summary
CardioDx Inc. (developing cardiovascular diagnostics) has brought in $34.6mm of a potential $44.5mm Series D venture round. GE Healthcare led the financing with a $5mm investment through its newly formed Healthymagination Fund. Fellow first-time backer DAG Ventures was joined by current shareholders Asset Management, Kleiner Perkins Caufield & Byers, Intel Capital, Mohr Davidow Ventures, Pappas Ventures, and TPG Ventures, as well as seven other undisclosed investors.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CardioDx gets $34.6mm through Series D venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice